---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-287241"
form_type: "8-K"
ticker: "MDXG"
cik: "0001376339"
company_name: "MIMEDX GROUP, INC."
filed_at: "2022-11-17T23:59:59+00:00"
generated_at: "2026-06-21T16:33:46.991102+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# MiMedx attends Canaccord conference with standard investor presentation

## Summary
- Executives attending Canaccord MedTech Forum on Nov 17, 2022; slide deck furnished as Exhibit 99.1.
- Slide deck titled 'A Pioneer & Leader in Placental Biologics'; no new financial data disclosed.
- Filing under Regulation FD; information not deemed filed or incorporated by reference.
- No material operational or financial updates provided in the 8-K or exhibit.

## SEC filing metadata
- accession: 0001193125-22-287241
- form_type: 8-K
- ticker: MDXG
- cik: 0001376339
- company_name: MIMEDX GROUP, INC.
- filed_at: 2022-11-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1376339/000119312522287241/0001193125-22-287241-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1376339/000119312522287241/d773724d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-287241
- JSON: https://secwatch.observer/filing/0001193125-22-287241.json
- Plain text: https://secwatch.observer/filing/0001193125-22-287241.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.